A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
NCT04194775
Adenocarcinoma, Carcinoma
Coronado, California, United States
View Trial DetailsNCT Number: NCT06018857
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.
Time frame: From date of surgery to date of death, up to 10 years after the surgery.
Federico Aucejo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04194775
Adenocarcinoma, Carcinoma
Coronado, California, United States
View Trial DetailsNCT06710223
Adenocarcinoma, Carcinoma
San Diego, California, United States
View Trial DetailsNCT02772003
Adenocarcinoma, Blood-Borne Infections
Jacksonville, Florida, United States
View Trial DetailsNCT03298451
Adenocarcinoma, Carcinoma
Los Angeles, California, United States
View Trial Details